22.85
1.38%
0.31
Dopo l'orario di chiusura:
22.85
Precedente Chiudi:
$22.54
Aprire:
$22.51
Volume 24 ore:
818.20K
Relative Volume:
1.26
Capitalizzazione di mercato:
$2.74B
Reddito:
$1.70B
Utile/perdita netta:
$14.93M
Rapporto P/E:
190.42
EPS:
0.12
Flusso di cassa netto:
$87.89M
1 W Prestazione:
+1.20%
1M Prestazione:
+16.88%
6M Prestazione:
+10.17%
1 anno Prestazione:
+13.34%
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Confronta PRVA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
22.85 | 2.74B | 1.70B | 14.93M | 87.89M | 0.12 |
VEEV
Veeva Systems Inc
|
233.26 | 37.87B | 2.66B | 665.91M | 1.08B | 4.05 |
SOLV
Solventum Corp
|
74.06 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
DOCS
Doximity Inc
|
59.10 | 11.03B | 516.85M | 174.11M | 217.38M | 0.87 |
HQY
Healthequity Inc
|
110.42 | 9.57B | 1.15B | 96.70M | -161.99M | 1.09 |
TEM
Tempus Ai Inc
|
57.39 | 9.04B | 640.44M | -743.28M | -206.93M | -11.29 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-10 | Iniziato | Needham | Buy |
2024-12-16 | Iniziato | Macquarie | Outperform |
2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
2024-05-30 | Iniziato | Robert W. Baird | Outperform |
2024-04-22 | Iniziato | Citigroup | Buy |
2024-03-06 | Iniziato | Barclays | Equal Weight |
2024-02-26 | Ripresa | Jefferies | Buy |
2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
2023-06-13 | Iniziato | Evercore ISI | Outperform |
2023-04-12 | Iniziato | Stephens | Overweight |
2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
2023-02-03 | Iniziato | Goldman | Buy |
2022-12-09 | Iniziato | Stifel | Buy |
2022-12-08 | Iniziato | UBS | Buy |
2022-09-07 | Ripresa | Truist | Buy |
2022-05-03 | Iniziato | BofA Securities | Buy |
2022-04-28 | Iniziato | BTIG Research | Buy |
2022-04-01 | Ripresa | Credit Suisse | Outperform |
2022-03-30 | Iniziato | Guggenheim | Buy |
2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
2022-01-03 | Iniziato | Jefferies | Buy |
2021-09-27 | Iniziato | SVB Leerink | Outperform |
2021-09-10 | Iniziato | Cowen | Market Perform |
2021-05-24 | Iniziato | Canaccord Genuity | Buy |
2021-05-24 | Iniziato | Credit Suisse | Outperform |
2021-05-24 | Iniziato | JP Morgan | Overweight |
2021-05-24 | Iniziato | Piper Sandler | Overweight |
2021-05-24 | Iniziato | Truist | Buy |
2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Privia Health Group, Inc. (NASDAQ:PRVA) Position Increased by Nisa Investment Advisors LLC - Defense World
Park Avenue Securities LLC Increases Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 - The Manila Times
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 - GlobeNewswire Inc.
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by Riverbridge Partners LLC - MarketBeat
Privia Health Group (NASDAQ:PRVA) Sets New 1-Year HighHere's What Happened - MarketBeat
Privia Health stock hits 52-week high at $23.38 amid market optimism - Investing.com
An Intrinsic Calculation For Privia Health Group, Inc. (NASDAQ:PRVA) Suggests It's 49% Undervalued - Yahoo Finance
JPMorgan Chase & Co. Boosts Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
JPMorgan Chase & Co. Has $3.43 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Learn to Evaluate (PRVA) using the Charts - Stock Traders Daily
Critical Analysis: Vsee Health (NASDAQ:VSEE) & Privia Health Group (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Harbor Capital Advisors Inc. - Defense World
Insiders At Privia Health Group Sold US$898k In Stock, Alluding To Potential Weakness - Simply Wall St
Privia Health Group (NASDAQ:PRVA) Research Coverage Started at Needham & Company LLC - Defense World
Needham Initiates Coverage of Privia Health Group (PRVA) with Buy Recommendation - MSN
Privia Health stock backed by Needham for strong 2025 outlook in VBC space - Investing.com Australia
Privia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at Needham & Company LLC - MarketBeat
Nordea Investment Management AB Purchases 86,910 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.88 Consensus Target Price from Analysts - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Buy” by Brokerages - Defense World
Privia Health Group (NASDAQ:PRVA) Receives “Overweight” Rating from Stephens - Defense World
A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts - Benzinga
Privia Health Group (NASDAQ:PRVA) Given Overweight Rating at Stephens - MarketBeat
Privia Health Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
When (PRVA) Moves Investors should Listen - Stock Traders Daily
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by MML Investors Services LLC - Defense World
Geode Capital Management LLC Grows Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
HighTower Advisors LLC Has $338,000 Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Position Decreased by Principal Financial Group Inc. - MarketBeat
Barclays PLC Acquires 158,188 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
DH vs. PRVA: Which Stock Is the Better Value Option? - Yahoo Finance
Franklin Resources Inc. Grows Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Stifel Financial Corp Has $2.41 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
State Street Corp Lowers Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Shares Down 5.2%Should You Sell? - MarketBeat
3 US Stocks That May Be Trading Below Their Estimated Value - Simply Wall St
Privia Health Group (NASDAQ:PRVA) Now Covered by Macquarie - Defense World
Macquarie sets shares price target on Privia Health, cites growth By Investing.com - Investing.com Australia
Macquarie Initiates Coverage on Privia Health Group (NASDAQ:PRVA) - MarketBeat
Macquarie sets shares price target on Privia Health, cites growth - Investing.com
Privia Health's SWOT analysis: navigating growth in a complex healthcare stock landscape - Investing.com Australia
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.79 Consensus Target Price from Brokerages - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Buy” from Brokerages - Defense World
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):